Abstract
A renal transplant recipient treated with immunosuppressive agents complained of blurred vision in 1 eye. Hemorrhages and fluffy, white retinal lesions were seen in both fundi. Cytomegalovirus (CMV) DNA was detected in the vitreous. Dosages of cyclosporine and methylprednisolone were decreased, and the azathioprine regimen was discontinued. No anti-CMV agents were given. The retinitis diminished markedly. Possibly, CMV retinitis in immunosuppressive conditions other than acquired immunodeficiency syndrome may regress if dosages of immunosuppressive drugs are decreased.
Similar content being viewed by others
References
de Venecia G, Rhein GMZ, Kisken W. Cytomegalic inclusion retinitis in an adult. Arch Ophthalmol. 1971;86:44–57.
Aaberg TM, Cezarz TJ, Rytel MW. Correlation of virology and clinical course of cytomegalovirus retinitis. Am J Ophthalmol. 1972; 74:407–415.
Wyhinny GJ, Apple DJ, Guastella FR, Vygantas CM. Adult cytomegalic inclusion retinitis. Am J Ophthalmol 1973;76:773–781.
Carson S, Chatterjee SN. Cytomegalovirus retinitis: two cases occurring after renal transplantation. Ann Ophthalmol 1978;10: 275–279.
Pollard RB, Egbert PR, Gallagher JG, Merigan TC. Cytomegalovirus retinitis in immunosuppressed hosts: I. Natural history and effects of treatment with adenine arabinoside. Ann Intern Med. 1980;93:655–664.
Egbert PR, Pollard RB, Gallagher JG, Merigan TC. Cytomegalovirus retinitis in immunosuppressed hosts. II. Ocular manifestations. Ann Intern Med. 1980;93:664–670.
Hennis HL, Scott AA, Apple DJ. Cytomegalovirus retinitis. Surv Ophthalmol. 1989;34:193–203.
Jabs DA, Enger C, Bartlett JG. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol. 1989; 107:75–80.
Palestine AG, Polis MA, De Smet MD, et al. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patient with AIDS. Ann Intern Med. 1991;115:665–673.
Bower EF, Wilson P, Atkins M, et al. Natural history of untreated cytomegalovirus retinitis. Lancet. 1995;346:1671–1673.
Wu AW, Coleson LC, Holbrook J, Jabs DA. Measuring visual function and quality of life in patients with cytomegalovirus retinitis. Arch Ophthalmol. 1996;114:841–847.
Hodge WG, Lalonde RG, Sampalis J, Deschenes J. Once-weekly intraocular injections of ganciclovir for maintenance therapy of cytomegalovirus retinitis: clinical and ocular outcome. J Infect Dis. 1996;174:393–396.
Masur H, Whitcup SM, Cartwright C, Polis M, Nussenblatt R. Advances in the management of AIDS-related cytomegalovirus retinitis. Ann Intern Med. 1996;125:126–136.
Studies of ocular complications of AIDS research group in collaboration with the AIDS Clinical Trial Group: foscarnet-ganciclovir cytomegalovirus retinitis trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Am J Ophthalmol. 1997; 124:141–157.
Reed IB, Schwab IR, Gordon J, Morse LS. Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS. Am J Ophthamol. 1975;124:199–205.
Musch DC, Martin DF, Gordon JF, Davis MD, Kuppermann B. Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. N Engl J Med. 1997;337:83–90.
Knox CM, Chandler D, Short GA, Margolis TP: Polymerase chain reaction-assays of vitreous samples for the diagnosis of viral retinitis: use in diagnostic dilemmas. Ophthalmology. 1998;105:37–45.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hayasaka, Y., Hayasaka, S., Watanabe, K. et al. Regression of cytomegalovirus retinitis after decreased doses of immunosuppressive agents in a renal transplant recipient. Ann Ophthalmol 32, 325–327 (2000). https://doi.org/10.1007/s12009-000-0073-7
Issue Date:
DOI: https://doi.org/10.1007/s12009-000-0073-7